Impact of supplementing Limosilactobacillus fermentum MN–LF23 on the eradication of Helicobacter pylori with 14–day standard quadruple therapy: a randomized, double–blind, placebo–controlled trial
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
No abstract available